Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-054029

Director sold 10,000 shares at $7.26 ($72,585)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2015-09-03 Option exercise +10,000 $0.88 $8,750 65,746 D
Kraus Al Director 2015-09-03 Sale −10,000 $7.26 $72,585 55,746 D
Derivatives
Kraus Al Director 2015-09-03 Option exercise · Stock Option −10,000 66,773 D
Open-market sales · 10,000 sh · avg $7.26 · $72,585
Loading xslF345X03/v419935_4.xml…